Anavex Life Sciences
AVXL
#7563
Rank
NZ$0.68 B
Marketcap
NZ$7.62
Share price
-1.12%
Change (1 day)
-41.05%
Change (1 year)

Anavex Life Sciences (AVXL) - Total assets

Total assets on the balance sheet as of June 2025 : NZ$0.17 Billion

According to Anavex Life Sciences 's latest financial reports the company's total assets are NZ$0.17 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Anavex Life Sciences - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-09-30NZ$0.21 B-17.04%
2023-09-30NZ$0.25 B-4.94%
2022-09-30NZ$0.27 B15.61%
2021-09-30NZ$0.23 B349.29%
2020-09-30NZ$52.15 M28.95%
2019-09-30NZ$40.44 M2.23%
2018-09-30NZ$39.56 M2.21%
2017-09-30NZ$38.71 M195.86%
2016-09-30NZ$13.08 M-45.96%
2015-09-30NZ$24.21 M157.13%
2014-09-30NZ$9.41 M1885.42%
2013-09-30NZ$0.47 M2885.13%
2012-09-30NZ$0.01 M-93.99%
2011-09-30NZ$0.26 M-41.15%
2010-09-30NZ$0.44 M-21.49%
2009-09-30NZ$0.57 M5241.6%
2008-09-30NZ$0.01 M32763.93%
2007-09-30NZ$0 M-99.83%
2006-09-30NZ$0.01 M1253.47%
2005-09-30NZ$0 M-96.62%
2004-09-30NZ$0.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$2.55 B 1,341.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$0.77 B 335.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$1.42 B 704.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$6.45 M-96.36%๐Ÿ‡บ๐Ÿ‡ธ USA